Brief: Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ
BRIEF-Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ July 1 (Reuters) -
TAKEDA, INSILICO STRIKE AI DRUG-DISCOVERY DEAL WORTH UP TO $600 MILLION - WSJ
TAKEDA WILL BE GRANTED EXCLUSIVE WORLDWIDE RIGHTS UNDER INSILICO DEAL TO DEVELOP, MANUFACTURE AND COMMERCIALIZE NEW DRUGS - WSJ
Source text: [ID: https://tinyurl.com/23bhpefm]
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)